Pancreatic head resectable adenocarcinoma: Preoperative chemoradiation improves local control but does not affect survival

HPB

Volumn 13, Issue 1, 2011, Pages 64-69

  Barbier, Louise ^a   Turrini, Olivier ^b   Grégoire, Emilie ^a   Viret, Frédéric ^c   Le Treut, Yves Patrice ^a   Delpero, Jean Robert ^b  

^a HÔPITAL DE LA CONCEPTION   (France)

^b Department of Surgical Oncology ^*  (France)

^c INSTITUT PAOLI CALMETTES   (France)

Author keywords

adenocarcinoma < pancreatic neoplasia; radiotherapy < pancreatic neoplasia; resection < pancreatic neoplasia

Indexed keywords

ADULT; AGED; ARTICLE; CHEMOTHERAPY; CONTROLLED STUDY; HUMAN; MAJOR CLINICAL STUDY; MORBIDITY; PANCREAS ADENOCARCINOMA; PANCREATIC HEAD ADENOCARCINOMA; PREOPERATIVE CARE; RADIOTHERAPY; SURVIVAL; TUMOR RECURRENCE; TUMOR VOLUME;

EID: 78650374310     PISSN: 1365182X     EISSN: 14772574     Source Type: Journal    
DOI: 10.1111/j.1477-2574.2010.00245.x     Document Type: Article

References (17)

1. National Cancer Institute, US National Institutes of Health. (2010) Pancreatic Cancer Treatment. [Accessed 10 October 2010.
2. Garcea G, Dennison AR, Pattenden CJ, Neal CP, Sutton CD, Berry DP,. (2008) Survival following curative resection for pancreatic ductal adenocarcinoma. A systematic review of the literature. JOP 9: 99-132.
3. Mancuso A, Calabro F, Sternberg CN,. (2006) Current therapies and advances in the treatment of pancreatic cancer. Crit Rev Oncol Hematol 58: 231-241.
4. Neoptolemos JP, Stocken DD, Friess H, Bassi C, Dunn JA, Hickey H, et al.; European Study Group for Pancreatic Cancer. (2004) A randomized trial of chemotherapy after resection of pancreatic cancer. New Egypt J Med 350: 1200-1210.
5. Oettle H, Post S, Neuhaus P, Gellert K, Langrehr J, Ridwelski K, et al. (2007) Adjuvant chemotherapy with gemcitabine vs. observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial. JAMA 297: 267-277.
6. Evans DB, Varadhachary GR, Crane CH, Sun CC, Lee JE, Pisters PW, et al. (2008) Preoperative gemcitabine-based chemoradiation for patients with resectable adenocarcinoma of the pancreatic head. J Clin Oncol 21: 3496-3502.
7. Golcher H, Brunner T, Grabenbauer G, Merkel S, Papadopoulos T, Hohenberger W, et al. (2008) Preoperative chemoradiation in adenocarcinoma of the pancreas. A single-centre experience advocating a new treatment strategy. Eur J Surg Oncol 34: 756-764.
8. Mornex F, Girard N, Delpero JR, Partensky C,. (2005) Radiochemotherapy in the management of pancreatic cancer. Part I: neoadjuvant treatment. Semin Radiat Oncol 15: 226-234.
9. Varadhachary GR, Wolff RA, Crane CH, Sun CC, Lee JE, Pisters PW, et al. (2008) Preoperative gemcitabine and cisplatine followed by gemcitabine-based chemoradiation for resectable adenocarcinoma of the pancreatic head. J Clin Oncol 21: 3487-3495.
10. Turrini O, Viret F, Moureau-Zabotto L, Guiramand J, Moutardier V, Lelong B, et al. (2009) Neoadjuvant 5-fluorouracil-cisplatin chemoradiation effect on survival in patients with resectable pancreatic head adenocarcinoma: a 10-year single-institution experience. Oncology 76: 413-419.
11. Le Scodan R, Mornex F, Partensky C, Mercier C, Valette PJ, Ychou M, et al. (2008) Histopathological response to preoperative chemoradiation for resectable pancreatic adenocarcinoma: the French phase II FFCD 9704-SFRO trial. Am J Clin Oncol 31: 545-552.
12. Child CG,. (1944) Pancreaticojejunostomy and other problems associated with the surgical management of carcinoma involving the head of the pancreas: report of five additional cases of radical pancreaticoduodenectomy. Ann Surg 119: 845-855.
13. Esposito I, Kleeff J, Bergmann F, Reiser C, Herpel E, Friess H, et al. (2008) Most pancreatic resections are R1 resections. Ann Surg Oncol 15: 1651-1660.
14. Bettini N, Moutardier V, Turrini O, Bories E, Monges G, Giovannini M, et al. (2005) Preoperative locoregional re-evaluation by endoscopic ultrasound in pancreatic ductal adenocarcinoma after neoadjuvant chemoradiation. Gastroenterol Clin Biol 29: 659-663.
15. Raut RP, Tseng JF, Sun CC, Wang H, Wolff RA, Crane CH, et al. (2007) Impact of resection status on pattern of failure and survival after pancreaticoduodenectomy for pancreatic adenocarcinoma. Ann Surg 246: 52-60.
16. Van den Broeck A, Sergeant G, Ectors N, Van Steenbergen W, Aerts R, Topal B,. (2009) Patterns of recurrence after curative resection of pancreatic ductal adenocarcinoma. Eur J Surg Oncol 35: 600-604.
17. Hernandez J, Mullinax J, Clark W, Toomey P, Villadolid D, Morton C, et al. (2009) Survival after pancreaticoduodenectomy is not improved by extending resections to achieve negative margins. Ann Surg 250: 76-78.